Annual SGA
$26.48 M
-$369.00 K-1.37%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual SGA is $26.48 million, with the most recent change of -$369.00 thousand (-1.37%) on December 31, 2023.
- During the last 3 years, RANI annual SGA has risen by +$21.51 million (+433.56%).
- RANI annual SGA is now -4.88% below its all-time high of $27.83 million, reached on December 31, 2021.
Performance
RANI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$5.63 M
-$782.00 K-12.20%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly SGA is $5.63 million, with the most recent change of -$782.00 thousand (-12.20%) on September 30, 2024.
- Over the past year, RANI quarterly SGA has dropped by -$782.00 thousand (-12.20%).
- RANI quarterly SGA is now -64.44% below its all-time high of $15.82 million, reached on September 30, 2021.
Performance
RANI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$334.40 M
-$28.17 M-9.20%
September 30, 2024
Summary
- As of February 8, 2025, RANI TTM SGA is -$334.40 million, with the most recent change of -$28.17 million (-9.20%) on September 30, 2024.
- Over the past year, RANI TTM SGA has dropped by -$359.72 million (-1420.69%).
- RANI TTM SGA is now -123.02% below its all-time high of $1.45 billion.
Performance
RANI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RANI Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -1.4% | -12.2% | -1420.7% |
3 y3 years | +433.6% | -12.2% | -1420.7% |
5 y5 years | +664.1% | -12.2% | -1420.7% |
RANI Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -4.9% | at low | -22.3% | at low | -593.7% | at low |
5 y | 5-year | -4.9% | +664.1% | -64.4% | +565.9% | -123.0% | +7.6% |
alltime | all time | -4.9% | +664.1% | -64.4% | +565.9% | -123.0% | +7.6% |
Rani Therapeutics Holdings Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $5.63 M(-12.2%) | $24.31 M(-4.0%) |
Jun 2024 | - | $6.41 M(-0.6%) | $25.32 M(-3.1%) |
Mar 2024 | - | $6.45 M(+10.6%) | $26.12 M(-1.3%) |
Dec 2023 | $26.48 M(-1.4%) | $5.83 M(-12.2%) | $26.48 M(-4.6%) |
Sep 2023 | - | $6.63 M(-7.9%) | $27.74 M(-2.1%) |
Jun 2023 | - | $7.21 M(+5.9%) | $28.35 M(+3.2%) |
Mar 2023 | - | $6.80 M(-4.1%) | $27.46 M(+2.3%) |
Dec 2022 | $26.84 M | $7.10 M(-2.0%) | $26.84 M(+4.5%) |
Sep 2022 | - | $7.24 M(+14.6%) | $25.69 M(-25.0%) |
Jun 2022 | - | $6.32 M(+2.1%) | $34.27 M(+9.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $6.19 M(+4.1%) | $31.42 M(+12.9%) |
Dec 2021 | $27.83 M(+460.9%) | $5.95 M(-62.4%) | $27.83 M(+17.4%) |
Sep 2021 | - | $15.82 M(+357.3%) | $23.71 M(+171.6%) |
Jun 2021 | - | $3.46 M(+32.7%) | $8.73 M(+41.7%) |
Mar 2021 | - | $2.61 M(+43.4%) | $6.16 M(+24.2%) |
Dec 2020 | $4.96 M(+43.2%) | $1.82 M(+115.1%) | $4.96 M(+57.8%) |
Sep 2020 | - | $845.00 K(-5.3%) | $3.14 M(+36.8%) |
Jun 2020 | - | $892.00 K(-36.6%) | $2.30 M(+63.4%) |
Mar 2020 | - | $1.41 M | $1.41 M |
Dec 2019 | $3.46 M | - | - |
FAQ
- What is Rani Therapeutics Holdings annual SGA?
- What is the all time high annual SGA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual SGA year-on-year change?
- What is Rani Therapeutics Holdings quarterly SGA?
- What is the all time high quarterly SGA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly SGA year-on-year change?
- What is Rani Therapeutics Holdings TTM SGA?
- What is the all time high TTM SGA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings TTM SGA year-on-year change?
What is Rani Therapeutics Holdings annual SGA?
The current annual SGA of RANI is $26.48 M
What is the all time high annual SGA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual SGA is $27.83 M
What is Rani Therapeutics Holdings annual SGA year-on-year change?
Over the past year, RANI annual SGA has changed by -$369.00 K (-1.37%)
What is Rani Therapeutics Holdings quarterly SGA?
The current quarterly SGA of RANI is $5.63 M
What is the all time high quarterly SGA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly SGA is $15.82 M
What is Rani Therapeutics Holdings quarterly SGA year-on-year change?
Over the past year, RANI quarterly SGA has changed by -$782.00 K (-12.20%)
What is Rani Therapeutics Holdings TTM SGA?
The current TTM SGA of RANI is -$334.40 M
What is the all time high TTM SGA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high TTM SGA is $1.45 B
What is Rani Therapeutics Holdings TTM SGA year-on-year change?
Over the past year, RANI TTM SGA has changed by -$359.72 M (-1420.69%)